Small Doses: June 24 to June 28
Drug Topics
JUNE 29, 2024
Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.
Sat.Jun 29, 2024
152 
STAT+: Supreme Court’s gutting of Chevron doctrine could mean headaches for drug industry
STAT
JUNE 29, 2024
The Food and Drug Administration’s power to make important regulatory decisions is in question after a Supreme Court decision weakening agencies ’ ability to interpret ambiguous statutory measures. The ruling could mean headaches not just for the teams of lawyers and scientists at the FDA, but for the drug and device companies the agency is charged with regulating.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
EU Leads in Biosimilar Market Access While US Lags Behind, Faces Challenges in Adoption
Pharmacy Times
JUNE 29, 2024
The European Union (EU) has successfully created a competitive market for biosimilars, while the US faces challenging market dynamics and tactics by pharmacy benefit managers that hinder the adoption of lower-cost therapies.
Opinion: What readers have to say about long Covid, FDA and diversity, and more
STAT
JUNE 29, 2024
First Opinion is STAT’s platform for interesting, illuminating, and maybe even provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to the Editor received in response to them.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Can you take Wegovy for PCOS?
The Checkup by Singlecare
JUNE 29, 2024
Polycystic ovary syndrome (PCOS) is a complex, often frustrating condition that causes a hormonal imbalance—typically an increase in androgens , or male sex hormones, which are any hormone capable of developing and maintaining masculine characteristics in reproductive tissues. Testosterone, for example, is an androgen. Women with PCOS experience irregular periods and difficulty losing weight due to insulin resistance.
Let's personalize your content